Clinical Trial Update: An Open-Label Treatment Protocol to Provide Metreleptin for the Treatment of Diabetes Mellitus and/or Hypertriglyceridemia Associated With Lipodystrophy [NA]

View source ↗

Summary

An open-label clinical trial protocol uses metreleptin to treat diabetes mellitus and/or hypertriglyceridemia associated with lipodystrophy, with the Bristol-My…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Hypertriglyceridemia
• Lipodystrophy

Drugs mentioned

• MYALEPT (METRELEPTIN)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Lipodystrophy | NA | Status: COMPLETED